View Transcript
Episode Description
- Akkermansia muciniphila has been associated with improved metabolic markers and immune function in research, with studies exploring its role in obesity and Type 2 diabetes
- Research suggests Akkermansia may support intestinal barrier function, which has been studied in relation to inflammatory bowel disease and colorectal cancer risk
- Research has explored Akkermansia's relationship with the gut-brain axis and conditions such as anxiety and Alzheimer's disease, primarily in preclinical models
- Akkermansia has also been studied for its potential role in stress-related research
- Akkermansia supplementation has been studied in two forms (live and pasteurized) in published human trials. The pasteurized form was associated with greater improvements in metabolic markers in a small proof-of-concept study, though larger trials are needed